BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35163224)

  • 1. Aberrant Methylation of 20 miRNA Genes Specifically Involved in Various Steps of Ovarian Carcinoma Spread: From Primary Tumors to Peritoneal Macroscopic Metastases.
    Loginov VI; Pronina IV; Filippova EA; Burdennyy AM; Lukina SS; Kazubskaya TP; Uroshlev LA; Fridman MV; Brovkina OI; Apanovich NV; Karpukhin AV; Stilidi IS; Kushlinskii NE; Dmitriev AA; Braga EA
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
    Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel miRNAs as Potential Regulators of PD-1/PD-L1 Immune Checkpoint, and Prognostic Value of MIR9-1 and MIR124-2 Methylation in Ovarian Cancer].
    Kushlinskii NE; Loginov VI; Utkin DO; Filippova EA; Burdennyy AM; Korotkova EA; Pronina IV; Lukina SS; Smirnova AV; Gershtein ES; Braga EA
    Mol Biol (Mosk); 2020; 54(6):990-996. PubMed ID: 33276362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Methylation of a Group of microRNA Genes in the Pathogenesis of Metastatic Renal Cell Carcinoma.
    Ivanova NA; Burdennyi AM; Lukina SS; Filippova EA; Pronina IV; Karpukhin AV; Matveev VB; Kazubskaya TP; Loginov VI; Braga EA; Kushlinskii NE
    Bull Exp Biol Med; 2023 Jun; 175(2):249-253. PubMed ID: 37466853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized Marker System for Early Diagnosis of Breast Cancer.
    Burdennyy AM; Filippova EA; Khodyrev DS; Pronina IV; Lukina SS; Ivanova NA; Kazubskaya TP; Loginov VI; Braga EA
    Bull Exp Biol Med; 2021 Nov; 172(1):57-62. PubMed ID: 34791555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant Methylation of 21 MicroRNA Genes in Breast Cancer: Sets of Genes Associated with Progression and a System of Markers for Predicting Metastasis.
    Loginov VI; Burdennyy AM; Filippova EA; Pronina IV; Lukina SS; Kazubskaya TP; Karpukhin AV; Khodyrev DS; Braga EA
    Bull Exp Biol Med; 2021 Nov; 172(1):67-71. PubMed ID: 34792716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypermethylation of miR-107, miR-130b, miR-203a, miR-1258 Genes Associated with Ovarian Cancer Development and Metastasis].
    Loginov VI; Burdennyy AM; Filippova EA; Pronina IV; Kazubskaya TP; Kushlinsky DN; Ermilova VD; Rykov SV; Khodyrev DS; Braga EA
    Mol Biol (Mosk); 2018; 52(5):801-809. PubMed ID: 30363055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features.
    Lee H; Park CS; Deftereos G; Morihara J; Stern JE; Hawes SE; Swisher E; Kiviat NB; Feng Q
    World J Surg Oncol; 2012 Aug; 10():174. PubMed ID: 22925189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy between the Levels of Methylation of microRNA Gene Sets in Primary Tumors and Metastases of Ovarian Cancer Patients.
    Lukina SS; Burdennyy AM; Filippova EA; Pronina IV; Ivanova NA; Kazubskaya TP; Kushlinskii DN; Utkin DO; Loginov VI; Braga EA; Kushlinskii NE
    Bull Exp Biol Med; 2022 May; 173(1):87-91. PubMed ID: 35622253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylated Genes of MicroRNA in Ovarian Carcinoma: Metastasis Prediction Marker Systems.
    Filippova EA; Loginov VI; Burdennyi AM; Braga EA; Pronina IV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Fridman MV; Khodyrev DS; Kushlinskii NE
    Bull Exp Biol Med; 2019 May; 167(1):79-83. PubMed ID: 31177462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of methylation of a group of miRNA genes in patients with ovarian cancer.].
    Kushlinskii NE; Utkin DO; Loginov VI; Filippova EA; Burdennyy AM; Kushlinsky DN; Pronina IV; Braga EA
    Klin Lab Diagn; 2020; 65(5):321-327. PubMed ID: 32298550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
    Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
    Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma.
    Tuncer SB; Erdogan OS; Erciyas SK; Saral MA; Celik B; Odemis DA; Turkcan GK; Yazici H
    J Ovarian Res; 2020 Aug; 13(1):99. PubMed ID: 32854743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma.
    Yu X; Zhang X; Bi T; Ding Y; Zhao J; Wang C; Jia T; Han D; Guo G; Wang B; Jiang J; Cui S
    Tumour Biol; 2013 Dec; 34(6):3501-8. PubMed ID: 23836287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of the Levels of microRNA Gene Methylation with the Level of Their Expression and Pathomorphological Characteristics of Breast Cancer.
    Filippova EA; Pronina IV; Lukina SS; Kazubskaya TP; Braga EA; Burdennyi AM; Loginov VI
    Bull Exp Biol Med; 2021 Oct; 171(6):764-769. PubMed ID: 34705180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis.
    Liu F; Zhang G; Lv S; Wen X; Liu P
    J Cell Biochem; 2019 Aug; 120(8):12618-12627. PubMed ID: 30834603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of PD-L1 between primary and metastatic epithelial ovarian cancer and its clinico-pathological correlation.
    Parvathareddy SK; Siraj AK; Al-Badawi IA; Tulbah A; Al-Dayel F; Al-Kuraya KS
    Sci Rep; 2021 Feb; 11(1):3750. PubMed ID: 33580098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer.
    Günel T; Gumusoglu E; Dogan B; Ertem FB; Hosseini MK; Cevik N; Senol T; Topuz S; Aydinli K
    Arch Gynecol Obstet; 2018 Dec; 298(6):1173-1180. PubMed ID: 30264202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of Genes in New Long Noncoding RNA in Ovarian Tumors and Metastases: A Dual Effect.
    Burdennyy AM; Filippova EA; Ivanova NA; Lukina SS; Pronina IV; Loginov VI; Fridman MV; Kazubskaya TP; Utkin DO; Braga EA; Kushlinskii NE
    Bull Exp Biol Med; 2021 Jul; 171(3):370-374. PubMed ID: 34292442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.
    Liang H; Yu T; Han Y; Jiang H; Wang C; You T; Zhao X; Shan H; Yang R; Yang L; Shan H; Gu Y
    Mol Cancer; 2018 Aug; 17(1):119. PubMed ID: 30098599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.